PSA PROFILES AFTER IODINE 125 PROSTATE BRACHYTHERAPY (BT)

被引：0
作者：
Crook, J. [1 ]
Gomez-Iturriga, A. [2 ]
Ma, C. [3 ]
Fung, S. [4 ]
机构：
[1] British Columbia Canc Agcy, Ctr Southern Interior, Dept Radiat Oncol, Kelowna, BC, Canada
[2] Univ Balboa, Dept Radiat Oncol, Balboa, Spain
[3] Princess Margaret Hosp, Dept Radiat Oncol, Toronto, ON, Canada
[4] Princess Margaret Hosp, Biostat, Toronto, ON, Canada
来源：
RADIOTHERAPY AND ONCOLOGY | 2010年 / 96卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
309
引用
收藏
页码：S118 / S118
页数：1
相关论文
共 50 条
  • [31] Influence of dose on risk of acute urinary retention after iodine-125 prostate brachytherapy
    Department of Radiation Oncology, University Medical Center Utrecht, Heidelberglaan 100, Utrecht 3584 CX, Netherlands
    不详
    Int. J. Radiat. Oncol. Biol. Phys., 4 (1072-1079):
  • [32] Incidence and clinical course of hemorrhagic radiation proctitis after iodine-125 prostate brachytherapy
    Mishra, Mark V.
    Shirazi, Reza
    Barrett, William L.
    CLINICAL GENITOURINARY CANCER, 2007, 5 (06) : 397 - 400
  • [33] Changes in lower urinary tract symptoms after iodine-125 brachytherapy for prostate cancer
    Onishi, Kenta
    Tanaka, Nobumichi
    Miyake, Makito
    Nakai, Yasushi
    Anai, Satoshi
    Torimoto, Kazumasa
    Yamaki, Kaori
    Asakawa, Isao
    Hasegawa, Masatoshi
    Fujii, Tomomi
    Konishi, Noboru
    Fujimoto, Kiyohide
    CLINICAL AND TRANSLATIONAL RADIATION ONCOLOGY, 2019, 14 : 51 - 58
  • [34] Focal salvage Iodine-125 brachytherapy for recurrent prostate cancer after primary radiotherapy
    Peters, M.
    Maenhout, M.
    Van Zyp, J. R. N. van der Voort
    Moerland, M. A.
    Moman, M.
    Van der Heide, U. A.
    Steuten, L. M. G.
    Battermann, J. J.
    Van Deursen, M. J. H.
    Van Vulpen, M.
    RADIOTHERAPY AND ONCOLOGY, 2014, 111 : S27 - S27
  • [35] The impact of perineural invasion on biochemical outcome after permanent prostate iodine-125 brachytherapy
    Pina, Alfonso Gomez-Iturriaga
    Crook, Juanita Mary
    Kwan, Paul
    Borg, Jette
    Ma, Clement
    BRACHYTHERAPY, 2010, 9 (03) : 213 - 218
  • [36] Multivariable model development for mortality after total salvage Iodine-125 prostate brachytherapy
    Peters, M.
    van Zyp, J. R. N. Van der Voort
    Moerland, M. A.
    Hoekstra, C. J.
    Van de Pol, S.
    Westendorp, H.
    Maenhout, M.
    Kattevilder, R.
    Verkooijen, H. M.
    Van Rossum, P. S. N.
    Ahmed, H. U.
    Shah, T.
    Emberton, M.
    Van Vulpen, M.
    RADIOTHERAPY AND ONCOLOGY, 2016, 119 : S15 - S16
  • [37] Re: Five-Year Potency Preservation after Iodine-125 Prostate Brachytherapy
    Seftel, Allen D.
    JOURNAL OF UROLOGY, 2015, 193 (01) : 248 - 248
  • [38] PSA results after Iodine seed prostate brachytherapy in the UK with up to five years follow up
    Sooriakumaran, P
    Henderson, A
    Langley, SEM
    Laing, RW
    RADIOTHERAPY AND ONCOLOGY, 2004, 71 : S43 - S43
  • [39] Iodine-125 low-dose rate prostate brachytherapy
    Minami, Takafumi
    Fujimoto, Saizo
    Fujita, Kazutoshi
    INTERNATIONAL JOURNAL OF UROLOGY, 2025, 32 (02) : 130 - 137
  • [40] Rectal dose constraints for salvage iodine-125 prostate brachytherapy
    Peters, Max
    Hoekstra, Carel J.
    van Zyp, Jochem R. N. van der Voort
    Westendorp, Hendrik
    van de Pol, Sandrine M. G.
    Moerland, Marinus A.
    Maenhout, Metha
    Kattevilder, Rob
    van Vulpen, Marco
    BRACHYTHERAPY, 2016, 15 (01) : 85 - 93
12345